Predictors of Systemic Exposure to Topical Crisaborole: A Nonlinear Regression Analysis

von Purohit, Vivek, Riley, Steve, Tan, Huaming, Ports, William C.
Veröffentlicht in J Clin Pharmacol (2020)

Under-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan Data

von Armstrong, April W., Koning, J. Will, Rowse, Simon, Tan, Huaming, Mamolo, Carla, Kaur, Mandeep
Veröffentlicht in Dermatol Ther (Heidelb) (2016)

CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis

von Xin, Xiaoyan, Zeng, Xianqin, Gu, Huajian, Li, Min, Tan, Huaming, Jin, Zhishan, Hua, Teng, Shi, Rui, Wang, Hongbo
Veröffentlicht in Sci Rep (2016)

Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis

von Valenzuela, Fernando, Papp, Kim A, Pariser, David, Tyring, Stephen K, Wolk, Robert, Buonanno, Marjorie, Wang, Jeff, Tan, Huaming, Valdez, Hernan
Veröffentlicht in BMC Dermatol (2015)

Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposu...

von Burmester, Gerd R, Nash, Peter, Sands, Bruce E, Papp, Kim, Stockert, Lori, Jones, Thomas V, Tan, Huaming, Madsen, Ann, Valdez, Hernan, Cohen, Stanley B
Veröffentlicht in RMD Open (2021)

Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups

von Callender, Valerie D., Alexis, Andrew F., Stein Gold, Linda F., Lebwohl, Mark G., Paller, Amy S., Desai, Seemal R., Tan, Huaming, Ports, William C., Zielinski, Michael A., Tallman, Anna M.
Veröffentlicht in Am J Clin Dermatol (2019)